The University of Cambridge and the University of Bristol conducted investigations of the research.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.

From a self-sampling scientist to the downfall of a leading stem cell scientist, here’s our naughty list.

It’s the latest fallout from an investigation by Harvard and Brigham and Women’s into work overseen by Piero Anversa.

It includes more than 18,000 papers and conference materials that have been retracted since the 1970s.

Controversy surrounding a mathematical model to explain the so-called “greater variability of males” hypothesis fells two versions of a paper—but critics of the work wish it were still published.

The ex-Wayne State University scientist has racked up 33 retractions to date. 

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.